Matches in Nanopublications for { ?s ?p "[For brain metastases, FOXA1 expression was slightly higher in the SCC samples (55.6%) compared with the non-matched primary SCC tumor samples (43.4%), whereas NKX2-1 expression was comparable in both primary tumors and brain metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP668044.RAqGODJW8L8nWBJQgpfutXVq7eteaDa_zE0wZ2wbNtUPs130_assertion description "[For brain metastases, FOXA1 expression was slightly higher in the SCC samples (55.6%) compared with the non-matched primary SCC tumor samples (43.4%), whereas NKX2-1 expression was comparable in both primary tumors and brain metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668044.RAqGODJW8L8nWBJQgpfutXVq7eteaDa_zE0wZ2wbNtUPs130_provenance.
- assertion description "[For brain metastases, FOXA1 expression was slightly higher in the SCC samples (55.6%) compared with the non-matched primary SCC tumor samples (43.4%), whereas NKX2-1 expression was comparable in both primary tumors and brain metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP461033.RAf6vo-jwDHkKJ86Vigh2TJEexyNgc_YDUF34bCZ3mot0130_assertion description "[For brain metastases, FOXA1 expression was slightly higher in the SCC samples (55.6%) compared with the non-matched primary SCC tumor samples (43.4%), whereas NKX2-1 expression was comparable in both primary tumors and brain metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP461033.RAf6vo-jwDHkKJ86Vigh2TJEexyNgc_YDUF34bCZ3mot0130_provenance.
- NP609253.RALWvrXK5D5IQwY3JrqVVo4EaElZ56Ubuz8l1WLE1b2mk130_assertion description "[For brain metastases, FOXA1 expression was slightly higher in the SCC samples (55.6%) compared with the non-matched primary SCC tumor samples (43.4%), whereas NKX2-1 expression was comparable in both primary tumors and brain metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP609253.RALWvrXK5D5IQwY3JrqVVo4EaElZ56Ubuz8l1WLE1b2mk130_provenance.
- assertion description "[For brain metastases, FOXA1 expression was slightly higher in the SCC samples (55.6%) compared with the non-matched primary SCC tumor samples (43.4%), whereas NKX2-1 expression was comparable in both primary tumors and brain metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[For brain metastases, FOXA1 expression was slightly higher in the SCC samples (55.6%) compared with the non-matched primary SCC tumor samples (43.4%), whereas NKX2-1 expression was comparable in both primary tumors and brain metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP739202.RA-SXhS92U-WSKNrA7jlr7xL9dSCkStD5HrQu0P8rgqeA130_assertion description "[For brain metastases, FOXA1 expression was slightly higher in the SCC samples (55.6%) compared with the non-matched primary SCC tumor samples (43.4%), whereas NKX2-1 expression was comparable in both primary tumors and brain metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP739202.RA-SXhS92U-WSKNrA7jlr7xL9dSCkStD5HrQu0P8rgqeA130_provenance.
- NP739314.RA3OBa-g1f4by-NP_EzhDGOayFFv11G3-gc6FFnwH1mU8130_assertion description "[For brain metastases, FOXA1 expression was slightly higher in the SCC samples (55.6%) compared with the non-matched primary SCC tumor samples (43.4%), whereas NKX2-1 expression was comparable in both primary tumors and brain metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP739314.RA3OBa-g1f4by-NP_EzhDGOayFFv11G3-gc6FFnwH1mU8130_provenance.
- NP964807.RAEY779iE4M3CgCPPfCj5sMRWZHTFukCjZBBNS401D7TQ130_assertion description "[For brain metastases, FOXA1 expression was slightly higher in the SCC samples (55.6%) compared with the non-matched primary SCC tumor samples (43.4%), whereas NKX2-1 expression was comparable in both primary tumors and brain metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964807.RAEY779iE4M3CgCPPfCj5sMRWZHTFukCjZBBNS401D7TQ130_provenance.
- NP964819.RAJ9ufX2vDKmi6vKN6RIbKX45-beoMjDYMLSLPyD_ienw130_assertion description "[For brain metastases, FOXA1 expression was slightly higher in the SCC samples (55.6%) compared with the non-matched primary SCC tumor samples (43.4%), whereas NKX2-1 expression was comparable in both primary tumors and brain metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964819.RAJ9ufX2vDKmi6vKN6RIbKX45-beoMjDYMLSLPyD_ienw130_provenance.
- NP964810.RAzCmrJ-ZoDEKnY5I92-wvaiqsfrF5qHV6casrRqGfFxU130_assertion description "[For brain metastases, FOXA1 expression was slightly higher in the SCC samples (55.6%) compared with the non-matched primary SCC tumor samples (43.4%), whereas NKX2-1 expression was comparable in both primary tumors and brain metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964810.RAzCmrJ-ZoDEKnY5I92-wvaiqsfrF5qHV6casrRqGfFxU130_provenance.